MenQuadfi, Vaccines & biologics, Product Catalog
4.5 (323) · € 33.00 · En Stock
Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older
Vaccines, Free Full-Text
Vaccines & biologics, Product Catalog
DJPH - Vaccine Preventable Disease by Delaware Academy of Medicine and the Delaware Public Health Association - Issuu
Vaccines & biologics, Product Catalog
Full article: Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
Immunization: Vaccine Updates Beyond COVID-19
Meningococcal Vaccine Market Size, Share, Opportunities & Forecast
Vaccines & biologics, Product Catalog
Document
Meningococcal Meningitis (MenACWY) Vaccine MenQuadfi® (Meningococcal [Groups A, C, Y, W] Conjugate Vaccine)
Adult Vaccines - Vaccination Treatment - Vaccine Distributor
